High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
暂无分享,去创建一个
[1] Cole Rd,et al. Specific interaction between H1 histone and high mobility protein HMG1. , 1994 .
[2] A. Thomson. The cytokine handbook , 1994 .
[3] C. Anasetti,et al. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. , 2003, Transplant immunology.
[4] V. Allfrey,et al. Estradiol enhanced acetylation of nuclear high mobility group proteins of the uterus of newborn guinea pigs. , 1989, Biochemical and biophysical research communications.
[5] H. Huttunen,et al. Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.
[6] I. Douglas,et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[7] Š. Pospíšilová,et al. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops. , 2004, Biochemistry.
[8] U. Andersson,et al. HMGB1 is a potent trigger of arthritis , 2004, Journal of internal medicine.
[9] T. Ogihara,et al. Direct in vivo gene introduction into rat kidney. , 1992, Biochemical and biophysical research communications.
[10] M. Fink,et al. Ethyl Pyruvate Provides Durable Protection Against Inflammation-Induced Intestinal Epithelial Barrier Dysfunction , 2003, Shock.
[11] M. Bianchi,et al. High mobility group box 1 protein, a cue for stem cell recruitment. , 2004, Biochemical pharmacology.
[12] A. Aguzzi,et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.
[13] M. Colonna,et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas , 2003, The Journal of pathology.
[14] H. Kuniyasu,et al. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. , 2003, Oncology reports.
[15] H. Rauvala,et al. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. , 1991, The Journal of biological chemistry.
[16] A. Reimold,et al. TNFalpha as therapeutic target: new drugs, more applications. , 2002, Current drug targets. Inflammation and allergy.
[17] M. Bustin,et al. Chromosomal Proteins HMGN3a and HMGN3b Regulate the Expression of Glycine Transporter 1 , 2004, Molecular and Cellular Biology.
[18] H. Harris,et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. , 2003, Arthritis and rheumatism.
[19] B. Nordén,et al. Vesicle membrane interactions of penetratin analogues. , 2004, Biochemistry.
[20] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[21] M. Andrassy,et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. , 2003, The Journal of clinical investigation.
[22] A. Schmidt,et al. Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.
[23] M. Bianchi,et al. HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. , 2003, Gene expression patterns : GEP.
[24] E. Alexandrova,et al. Differences between HMG1 proteins isolated from normal and tumour cells. , 1987, Biochimica et biophysica acta.
[25] D. Edwards,et al. Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[26] J. Stetkiewicz,et al. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation. , 2004, International journal of occupational medicine and environmental health.
[27] A. Ridley,et al. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.
[28] H. Rosen,et al. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease , 2004, Hepatology.
[29] O. Hino,et al. Recombination Hot Spot of Hepatitis B Virus Genome Binds to Members of the HMG Domain Protein Family and the Y Box Binding Protein Family; Implication of These Proteins in Genomic Instability , 2001, Intervirology.
[30] M. Bianchi,et al. The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.
[31] M. Nakajima,et al. The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site , 2003, FEBS letters.
[32] I. Ito,et al. Conformational difference in HMGB1 proteins of human neutrophils and lymphocytes revealed by epitope mapping of a monoclonal antibody. , 2004, Journal of biochemistry.
[33] J. Enghild,et al. Regulation of receptor for advanced glycation end products during bleomycin-induced lung injury. , 2003, American journal of respiratory cell and molecular biology.
[34] P. Nawroth,et al. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. , 2004, Microbes and infection.
[35] K. Tracey,et al. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. , 2002, Cytokine.
[36] Y. Kuroda,et al. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. , 2004, Hepato-gastroenterology.
[37] R. Harpio,et al. S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. , 2004, Clinical biochemistry.
[38] Masaki Tanaka,et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. , 2004, American journal of respiratory and critical care medicine.
[39] Y. Hata,et al. Receptor for advanced glycation end‐products is a marker of type I lung alveolar cells , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[40] M. Torrisi,et al. CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D. , 2001, Blood.
[41] T. Kislinger,et al. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.
[42] H. Yokozaki,et al. Expression of receptors for advanced glycation end‐products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer , 2002, The Journal of pathology.
[43] D. Schatz,et al. Synapsis of Recombination Signal Sequences Located in cis and DNA Underwinding in V(D)J Recombination , 2004, Molecular and Cellular Biology.
[44] K. Takata,et al. High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity , 2004 .
[45] R. Sitia,et al. Entry of exogenous polypeptides into the nucleus of living cells: facts and speculations. , 1995, Trends in cell biology.
[46] K. Preissner,et al. The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins , 2003, The Journal of experimental medicine.
[47] K. Ikuta,et al. Borna Disease Virus Phosphoprotein Represses p53-Mediated Transcriptional Activity by Interference with HMGB1 , 2003, Journal of Virology.
[48] G. Mazariegos,et al. Dendritic Cell Subset Ratio in Peripheral Blood Correlates with Successful Withdrawal of Immunosuppression in Liver Transplant Patients , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[49] L. Borrmann,et al. Variation of HMGB1 expression in breast cancer. , 2001, Anticancer research.
[50] F. Yuan,et al. Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair* , 2004, Journal of Biological Chemistry.
[51] M. Lotze,et al. Dealing with death: HMGB1 as a novel target for cancer therapy. , 2003, Current opinion in investigational drugs.
[52] M. Lotze,et al. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. , 2005, Molecular immunology.
[53] L. A. Kohlstaedt,et al. Specific interaction between H1 histone and high mobility protein HMG1. , 1994, Biochemistry.
[54] K. Tracey,et al. Extracellular role of HMGB1 in inflammation and sepsis , 2004, Journal of internal medicine.
[55] J. Enghild,et al. Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)* , 2004, Journal of Biological Chemistry.
[56] K. Tracey,et al. HMGB1 in the immunology of sepsis (not septic shock) and arthritis. , 2004, Advances in immunology.
[57] J. Emond,et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice , 2004, Hepatology.
[58] Jun Yu Li,et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. , 2002, Arthritis and rheumatism.
[59] T. Giese,et al. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. , 2003, Cancer research.
[60] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[61] I. Grigorov,et al. HMG-1 as regulatory trans-acting protein in the acute phase-induced expression of the rat liver haptoglobin gene. , 2001, General physiology and biophysics.
[62] Hoguen Kim,et al. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. , 2003, Cancer research.
[63] Yan Yu,et al. [High mobility group box-1 protein activates Janus kinase-signal transducer and activator of transcription pathway in rat peritoneal macrophages]. , 2004, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.
[64] G. Goodwin,et al. Physical studies of the nonhistone chromosomal proteins HMG-U and HMG-2. , 1976, Biochemistry.
[65] A. Nakagawara,et al. HMGB1 and HMGB2 Cell-specifically Down-regulate the p53- and p73-dependent Sequence-specific Transactivation from the Human Bax Gene Promoter* , 2002, The Journal of Biological Chemistry.
[66] H. Huttunen,et al. Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation* , 2002, The Journal of Biological Chemistry.
[67] S. Rosenberg,et al. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. , 1985, Journal of immunology.
[68] K. Tracey,et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14‐ and TNF‐dependent mechanisms , 2004, Journal of leukocyte biology.
[69] Y. Kaneda,et al. Fusigenic liposome-mediated DNA transfer into cardiac myocytes. , 1996, Journal of molecular and cellular cardiology.
[70] J. Chu,et al. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. , 2003, The Journal of general virology.
[71] S. Maier,et al. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. , 2003, Cytokine.
[72] M. Bianchi,et al. Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent. , 1997, BioTechniques.
[73] F. Di Virgilio,et al. P2X(7) receptor and polykarion formation. , 2000, Molecular biology of the cell.
[74] M. Müller,et al. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. , 1998, Cellular and molecular biology.
[75] K. Tracey. Fatal Sequence: The Killer Within , 2005 .
[76] N. Kalinina,et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[77] Angela Panoskaltsis-Mortari,et al. Human Plasmacytoid Dendritic Cells Activated by CpG Oligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.
[78] M. Strauss,et al. Transfection by DNA-nuclear protein HMG1 complexes: raising of efficiency and role of DNA topology. , 1990, Archiv fur Geschwulstforschung.
[79] James R. Goldenring,et al. Gastric Cancer Originating from Bone Marrow-Derived Cells , 2004, Science.
[80] K. Tracey,et al. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock , 1999, The Lancet.
[81] M. Lotze,et al. Addicted to Death: Invasive Cancer and the Immune Response to Unscheduled Cell Death , 2005, Journal of immunotherapy.
[82] Michael Bustin,et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. , 2003, Blood.
[83] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[84] M. Bianchi,et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation , 2004, The Journal of cell biology.
[85] Chenguang Wang,et al. Acetylation of nuclear receptors in cellular growth and apoptosis. , 2004, Biochemical pharmacology.
[86] I. Davis,et al. ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. , 2003, Blood.
[87] S. Steinberg,et al. Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[88] K. Ikuta,et al. Borna Disease Virus Phosphoprotein Binds a Neurite Outgrowth Factor, Amphoterin/HMG-1 , 2001, Journal of Virology.
[89] R. Fisher,et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] L. Moreland,et al. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate , 2004, Annals of the rheumatic diseases.
[91] Gunnar P. H. Dietz,et al. Delivery of bioactive molecules into the cell: the Trojan horse approach , 2004, Molecular and Cellular Neuroscience.
[92] K. Tracey,et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.
[93] Eithne Costello,et al. High mobility group chromosomal protein 1 binds to the adeno‐associated virus replication protein (Rep) and promotes Rep‐mediated site‐specific cleavage of DNA, ATPase activity and transcriptional repression , 1997, The EMBO journal.
[94] F. Vogel,et al. Condensation of vector DNA by the chromosomal protein HMG1 results in efficient transfection. , 1988, Biochimica et biophysica acta.
[95] M. Bustin,et al. Immunological relatedness of high mobility group chromosomal proteins from calf thymus. , 1978, The Journal of biological chemistry.
[96] V. Pascual,et al. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. , 2002, Human immunology.
[97] T. Kislinger,et al. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB , 2005, The Journal of experimental medicine.
[98] J. Kwekkeboom,et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B , 2004, Hepatology.
[99] R. Re. The intracrine hypothesis and intracellular peptide hormone action. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[100] S. Rosenberg,et al. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. , 1985, Journal of immunology.
[101] K. Tracey,et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. , 2002, Gastroenterology.
[102] F. Katsuoka,et al. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. , 1997, Biochemical and biophysical research communications.
[103] Patrick L. Hindmarsh,et al. HMG Protein Family Members Stimulate Human Immunodeficiency Virus Type 1 and Avian Sarcoma Virus Concerted DNA Integration In Vitro , 1999, Journal of Virology.
[104] D. Shapiro,et al. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. , 1999, Molecular endocrinology.
[105] Qiang Wu,et al. Rice HMGB1 protein recognizes DNA structures and bends DNA efficiently. , 2003, Archives of biochemistry and biophysics.
[106] M. Bustin,et al. Chromatin subunits elicit species-specific antibodies against nucleoprotein antigenic determinants. , 1980, Biochemistry.
[107] K. Tracey,et al. Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner. , 2003, Virology.
[108] J. Palmblad,et al. High mobility group 1 B‐box mediates activation of human endothelium , 2003, Journal of internal medicine.
[109] E. Abraham,et al. Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.
[110] W. Trojaborg,et al. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[111] Tiziana Bonaldi,et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.
[112] F. Smith,et al. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK‐1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration , 2004, Journal of neurochemistry.
[113] K. Tracey,et al. CHAPTER 39 – HMGB-1 , 2003 .
[114] Polly Matzinger,et al. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.
[115] W. Fang,et al. The Significance of Changes in High Mobility Group-1 Protein mRNA Expression in Rats After Thermal Injury , 2002, Shock.
[116] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[117] M. Chandler,et al. Mutual stabilisation of bacteriophage Mu repressor and histone-like proteins in a nucleoprotein structure. , 1995, Journal of molecular biology.
[118] P. Rouleau,et al. Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.
[119] Yong‐jun Liu,et al. Mysterious origin of plasmacytoid dendritic cell precursors. , 2004, Immunity.
[120] K. Tracey,et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.
[121] H. Murua Escobar,et al. Expression pattern of the HMGB1 gene in sarcomas of the dog. , 2004, Anticancer research.
[122] H. Kuniyasu,et al. Differential effects between amphoterin and advanced glycation end products on colon cancer cells , 2003, International journal of cancer.
[123] James E. Evans,et al. Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.
[124] L. Murphy,et al. S100A7 and the progression of breast cancer , 2004, Breast Cancer Research.
[125] K. Tracey,et al. High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization , 2004, The Journal of Immunology.
[126] T. Darville,et al. Cell death, BAX activation, and HMGB1 release during infection with Chlamydia. , 2004, Microbes and infection.
[127] O. Box. Functional impairment of myeloid and plasmacytoid dendritic cells of pat ients with chronic hepatitis B , 2005 .
[128] Z. Izsvák,et al. The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. , 2003, Nucleic acids research.
[129] K. Tracey,et al. Lipid unites disparate syndromes of sepsis , 2004, Nature Medicine.
[130] P. Rouleau,et al. Proinflammatory Activities of S 100 : Proteins S 100 A 8 , S 100 A 9 , and S 100 A 8 / A 9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003 .
[131] H. Clevers,et al. Ancestry and diversity of the HMG box superfamily. , 1993, Nucleic acids research.
[132] J. Kuja-Panula,et al. Regulation of monocyte migration by amphoterin (HMGB1). , 2004, Blood.
[133] W. Zong,et al. Alkylating DNA damage stimulates a regulated form of necrotic cell death. , 2004, Genes & development.
[134] J. Wang,et al. Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. , 1978, Science.
[135] S. Knapp,et al. The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes. , 2004, Biochemistry.
[136] C. Dinarello,et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[137] S. Müller,et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells , 2004, EMBO reports.
[138] Giovanna Angelini,et al. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. , 2005, Blood.
[139] U. Andersson,et al. RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.
[140] K. Tracey,et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.
[141] P. Hersey,et al. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. , 2004, Molecular cancer therapeutics.